- Home
- CRNX vs NPO Comparison
CRNX vs NPO Comparison
Compare CRNX & NPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | NPO |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.7B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRNX | NPO |
|---|---|---|
| Price | $48.27 | $224.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $71.00 | ★ $243.33 |
| AVG Volume (30 Days) | ★ 992.2K | 176.3K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | N/A | ★ 58.40 |
| EPS | N/A | ★ 4.06 |
| Revenue | $1,535,000.00 | ★ $1,106,300,000.00 |
| Revenue This Year | $425.41 | $8.71 |
| Revenue Next Year | $943.30 | $9.74 |
| P/E Ratio | ★ N/A | $55.12 |
| Revenue Growth | ★ 47.74 | 6.44 |
| 52 Week Low | $24.10 | $133.50 |
| 52 Week High | $54.18 | $248.88 |
Technical Indicators
Market Signals| Indicator | CRNX | NPO |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 55.84 |
| Support Level | $43.04 | $204.25 |
| Resistance Level | $49.61 | $225.51 |
| Average True Range (ATR) | 2.04 | 7.03 |
| MACD | -0.16 | 0.93 |
| Stochastic Oscillator | 62.22 | 82.65 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About NPO Enpro Inc.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.